Evidence map›Paper›PMID 38836499›Full record

ArticleProtein engineering, design & selection : PEDS2024

Sequence-developability mapping of affibody and fibronectin paratopes via library-scale variant characterization.

Gregory H Nielsen, Zachary D Schmitz, Benjamin J Hackel

Abstract read
In one paragraph

Article in Protein engineering, design & selection : PEDS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gregory H NielsenDepartment of Chemical Engineering and Materials Science, University of Minnesota, Twin Cities, Minneapolis, MN 55455, United States.
Zachary D SchmitzDepartment of Chemical Engineering and Materials Science, University of Minnesota, Twin Cities, Minneapolis, MN 55455, United States.
Benjamin J HackelDepartment of Chemical Engineering and Materials Science, University of Minnesota, Twin Cities, Minneapolis, MN 55455, United States.ORCID 0000-0003-3561-9463

Funding

Engineering protein developabilityR01GM146372 · NIGMS · UNIVERSITY OF MINNESOTA · PI HACKEL, BENJAMIN · 2022 to 2025
$1.4M
NIGMS NIH HHS R01 GM146372NIH HHS R01 GM146372
6 · The paper itself

Abstract

Protein developability is requisite for use in therapeutic, diagnostic, or industrial applications. Many developability assays are low throughput, which limits their utility to the later stages of protein discovery and evolution. Recent approaches enable experimental or computational assessment of many more variants, yet the breadth of applicability across protein families and developability metrics is uncertain. Here, three library-scale assays-on-yeast protease, split green fluorescent protein (GFP), and non-specific binding-were evaluated for their ability to predict two key developability outcomes (thermal stability and recombinant expression) for the small protein scaffolds affibody and fibronectin. The assays' predictive capabilities were assessed via both linear correlation and machine learning models trained on the library-scale assay data. The on-yeast protease assay is highly predictive of thermal stability for both scaffolds, and the split-GFP assay is informative of affibody thermal stability and expression. The library-scale data was used to map sequence-developability landscapes for affibody and fibronectin binding paratopes, which guides future design of variants and libraries.

Indexed as

FibronectinsRecombinant Fusion ProteinsGreen Fluorescent ProteinsHumansPeptide LibraryProtein BindingProtein EngineeringProtein StabilityFibronectinsGreen Fluorescent ProteinsPeptide LibraryRecombinant Fusion Proteinsaffibodydevelopabilityfibronectinsequence-performance mapping

Identifiers

PMID38836499
PMCPMC11170491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.